[PDF][PDF] EVI1 基因阳性的儿童急性髓细胞性白血病生物学及临床特征分析
姜敏， 李小青， 胡东， 邱奕宁， 张志泉， 张冰玉… - 中国当代儿科 …, 2014 - zgddek.com
… Maintenance of the hematopoietic stem cell pool in bone marrow niches by EVI1… Activation
of EVI1 inhibits cell cycle progression and differentiation of hematopoietic progenitor cells…
of EVI1 inhibits cell cycle progression and differentiation of hematopoietic progenitor cells…
[PDF][PDF] 模式动物斑马鱼在人乳腺癌疾病研究中的应用进展
张敏， 张晶晶， 宁国柱 - 中国实验动物学报, 2023 - zgbjyx.cnjournals.com
… 新型转录靶标,基因EVI1 可通过调控KISS1 的转录 直接影响… , including preventing cell cycle,
inducing apoptosis and inhibiting … Nuclear SIPA1 activates integrin β1 promoter and promotes …
inducing apoptosis and inhibiting … Nuclear SIPA1 activates integrin β1 promoter and promotes …
白血病融合基因EVI1 的多态性与白血病发生风险的相关性.
石媛， 毕小朵， 杨光路， 李晓华… - Progress in Modern …, 2020 - search.ebscohost.com
… pathway inhibition alters GSK3 and WNT signaling in EVI1-… in the transformation of
hematopoietic stem and progenitor cells[J]. … Activation of EVI1 transcription by the LEF1/beta-catenin …
hematopoietic stem and progenitor cells[J]. … Activation of EVI1 transcription by the LEF1/beta-catenin …
[HTML][HTML] CCAAT 增强子结合蛋白α 与急性髓细胞白血病的发生
SHI Ting, YE Xiujin - Journal of Zhejiang University (Medical …, 2018 - ncbi.nlm.nih.gov
… a pretty crucial role in the regulation of myeloid hematopoiesis.The disorder of CEBPA gene
… In order to better guide medical decision-making, this article reviews research progress on C…
… In order to better guide medical decision-making, this article reviews research progress on C…
过表达组蛋白H3K9me3 去甲基化酶对猪克隆胚胎发育的影响
李亚楠， 张贤君， 张宁， 梁雅琳， 张宇星， 招华兴… - 遗传, 2022 - chinagene.cn
… 水的4细胞期克隆胚胎,放入含裂解液和RNase Inhibitor 的收集管中,随后快速放入液氮.总共
收集… gramming of histone acetylation and methylation in the first cell cycle of cloned mouse …
收集… gramming of histone acetylation and methylation in the first cell cycle of cloned mouse …
[PDF][PDF] 非编码RNA 研究进展
陈玲玲， 冯珊珊， 范祖森， 龚畅， 刘本宇… - 中国科学: 生命 …, 2019 - researchgate.net
… 与伦敦大学玛丽皇后学院William Harvey心脏中心肖庆忠教授团队 [65]针对血管损伤 后内膜
异常增生的机制发现, miR-22作为血管异常重 构性疾病治疗靶点, 能够通过调控MECP-2和EVI-1减 …
异常增生的机制发现, miR-22作为血管异常重 构性疾病治疗靶点, 能够通过调控MECP-2和EVI-1减 …